Cuprina Holdings (Cayman) LTD (CUPR)

Company

Cuprina Holdings (Cayman) LTD (CUPR)

StatusApr 10, 2025
BiotechnologyBiotechnology
Initial Public Offering / IPOInitial Public Offering / IPO

Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. For more information, please visit https://www.cuprina.com.

Chart/Sentiment

Financials

Cuprina Holdings (Cayman) LTD (CUPR)

Period endRevenue
2025-12-3120-F
38,789 USD
2024-12-3120-F
35,522 USD

Source: SEC Company Facts · USD. Some values may be calculated; please verify them against the official SEC filings.

Scroll to Top